Tuesday, Dec. 5, 2023: Cramer says these two Club holdings are a buy

Jim and Jeff discuss why there's an opportunity to buy these two holdings in the Charitable Trust. Jim also says that the current market sentiment toward this pharmaceutical stock is a mistake following the company's announcement that its obesity drug is now available in U.S. pharmacies. Finally, Jim explains why this megacap tech position is gaining right now.